Clinical trial
Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
NCT00177827 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177827 |
|---|---|
| Title | Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients |
| Official title | Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients: Pharmacokinetics and Correlation Between Plasma and Lung Concentrations With Toxicity/Efficacy |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Post Lung Transplantation |
| Enrollment | 104 |
| Start date | Mar 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: